During the past decade, Mercy Clinic St. Louis Cancer and Breast Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Clinic St. Louis Cancer and Breast Institute" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Clinic St. Louis Cancer and Breast Institute" are "Metastatic Breast Cancer" (2 trials), "Advanced Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Mercy Clinic St. Louis Cancer and Breast Institute" in a lesser frequency.

Most popular intervention types in "Mercy Clinic St. Louis Cancer and Breast Institute" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Fulvestrant" (1 trials), "Letrozole" (1 trials), "PD-0332991" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Clinic St. Louis Cancer and Breast Institute" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Clinic St. Louis Cancer and Breast Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mercy Clinic St. Louis Cancer and Breast Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Clinic St. Louis Cancer and Breast Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".